UPDATED May 13, 2024
Discover U.K. Pharmaceuticals & Biotech Growth Stocks that are on the FTSE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TRX | UK£0.61 | 0% | 9.8% | UK£43.3m | UK£1.20 | PS1.8x | E133.0% | n/a | ||
SAR | UK£0.36 | 50.5% | -70.8% | UK£39.0m | UK£1.76 | PB93.5x | E117.2% | n/a | ||
FUM | UK£0.40 | 7.9% | -5.9% | UK£119.7m | UK£1.26 | PS38.6x | E111.8% | n/a | ||
STX | UK£0.019 | 22.6% | -74.7% | UK£14.9m | n/a | PS1.4x | E101.9% | n/a | ||
OXB | UK£3.18 | -3.2% | -23.0% | UK£317.5m | UK£4.30 | PS3.5x | E100.4% | n/a | ||
LLAI | UK£0.26 | -1.9% | -49.0% | UK£7.8m | UK£2.20 | PS213.4x | E88.7% | n/a | ||
BVX | UK£0.12 | 0% | -23.3% | UK£9.5m | n/a | PB3.4x | E63.8% | n/a | ||
DPH | UK£38.66 | 0.2% | 32.4% | UK£4.4b | UK£37.59 | PS5.8x | E62.5% | 0% | ||
DXRX | UK£0.98 | 0% | 6.5% | UK£82.8m | UK£1.67 | PE13793.8x | E59.5% | n/a | ||
APH | UK£0.33 | 0% | -51.7% | UK£178.9m | n/a | PS1.1x | E47.8% | 0% | ||
EAH | UK£1.18 | 4.9% | -3.3% | UK£79.9m | UK£1.85 | PB1x | E46.3% | 0% | ||
SNG | UK£0.065 | 5.0% | -33.3% | UK£13.1m | n/a | PB0.8x | E40.6% | n/a | ||
AREC | UK£1.37 | -0.7% | -46.5% | UK£41.8m | UK£5.08 | PS12.4x | E38.1% | n/a | ||
INDV | UK£14.38 | 0.2% | -2.4% | UK£1.9b | UK£24.41 | PE488.2x | E34.7% | 0% | ||
ONT | UK£1.10 | -0.5% | -54.6% | UK£945.4m | UK£1.98 | PS5.6x | E24.0% | n/a | ||
GNS | UK£18.68 | 0% | -27.3% | UK£1.2b | UK£27.78 | PE36.7x | E21.5% | 1.7% | ||
HCM | UK£3.50 | 12.9% | 54.2% | UK£3.0b | UK£4.29 | PE37.2x | E18.2% | n/a | ||
HIK | UK£20.12 | 2.7% | 8.9% | UK£4.5b | UK£22.93 | PE29.5x | E16.0% | 2.9% | ||
AZN | UK£123.18 | 2.2% | 2.7% | UK£191.0b | UK£132.82 | PE37.9x | E15.9% | 2.0% | ||
OCTP | UK£0.0016 | -53.6% | -87.5% | UK£1.7m | n/a | PB0.9x | E15.1% | n/a | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
GSK | UK£18.10 | 4.4% | 23.2% | UK£73.8b | UK£20.32 | PE16.5x | E12.2% | 3.2% | ||
BVXP | UK£43.75 | 1.2% | 17.4% | UK£228.4m | UK£59.00 | PE26.4x | E5.2% | 3.5% | ||
PRTC | UK£2.23 | 1.8% | 7.5% | UK£603.0m | UK£4.90 | PS227.4x | E2.9% | n/a |